Nucala approved in China for use in severe asthma with an eosinophilic phenotype
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Arco Lab now holds a 50% stake in Neviton
Comprehensive clinical development programs being initiated for each investigational candidate
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Subscribe To Our Newsletter & Stay Updated